The ACLU and PUBPAT issued a press release today announcing that they are petitioning the U.S. Supreme Court to review the U.S. Federal Circuit’s decision upholding the patent-eligibility of isolated DNA. The release announces in part:
“The American Civil Liberties Union and the Public Patent Foundation today asked the U.S. Supreme Court to invalidate patents for two genes associated with hereditary breast and ovarian cancer that allow a Utah company to control access to crucial genetic tests that could lead to life-saving treatment.”
Our prior posts review the issues and history of the case. See
8/16/2012;
7/23/2012;
5/31/2012;
3/26/2012;
2/21/2012;
12/19/2011;
9/14/2011;
8/30/2011;
7/31/2011 and
7/29/2011.
A copy of the petition is attached [
Cert. Petition].
